SK242004A3 - Methyl analogs of simvastatin as novel HMG-CoA reductase inhibitors - Google Patents

Methyl analogs of simvastatin as novel HMG-CoA reductase inhibitors Download PDF

Info

Publication number
SK242004A3
SK242004A3 SK24-2004A SK242004A SK242004A3 SK 242004 A3 SK242004 A3 SK 242004A3 SK 242004 A SK242004 A SK 242004A SK 242004 A3 SK242004 A3 SK 242004A3
Authority
SK
Slovakia
Prior art keywords
solvent
organic solvent
methyl
simvastatin
vii
Prior art date
Application number
SK24-2004A
Other languages
English (en)
Slovak (sk)
Inventor
Rajesh Kumar Thaper
Saridi Madhava Dileep Kumar
Original Assignee
Ranbaxy Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Lab Ltd filed Critical Ranbaxy Lab Ltd
Publication of SK242004A3 publication Critical patent/SK242004A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/02—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen
    • C07C69/22—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen having three or more carbon atoms in the acid moiety
    • C07C69/30—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen having three or more carbon atoms in the acid moiety esterified with trihydroxylic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/30—Oxygen atoms, e.g. delta-lactones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/14—All rings being cycloaliphatic
    • C07C2602/26—All rings being cycloaliphatic the ring system containing ten carbon atoms
    • C07C2602/28—Hydrogenated naphthalenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SK24-2004A 2001-06-13 2002-06-10 Methyl analogs of simvastatin as novel HMG-CoA reductase inhibitors SK242004A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN659DE2001 2001-06-13
PCT/IB2002/002112 WO2002100323A2 (en) 2001-06-13 2002-06-10 METHYL ANALOGS OF SIMVASTATIN AS NOVEL HMG-CoA REDUCTASE INHIBITORS

Publications (1)

Publication Number Publication Date
SK242004A3 true SK242004A3 (en) 2004-06-08

Family

ID=11097071

Family Applications (1)

Application Number Title Priority Date Filing Date
SK24-2004A SK242004A3 (en) 2001-06-13 2002-06-10 Methyl analogs of simvastatin as novel HMG-CoA reductase inhibitors

Country Status (12)

Country Link
US (1) US6541511B1 (cs)
EP (1) EP1404313A4 (cs)
JP (1) JP2005500282A (cs)
CN (1) CN1535145A (cs)
BR (1) BR0210426A (cs)
CA (1) CA2450617A1 (cs)
CZ (1) CZ200450A3 (cs)
EA (1) EA200400034A1 (cs)
PL (1) PL367885A1 (cs)
SK (1) SK242004A3 (cs)
WO (1) WO2002100323A2 (cs)
ZA (1) ZA200400017B (cs)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101126084B1 (ko) * 2008-11-04 2012-03-29 한미홀딩스 주식회사 (3ｓ,4ｓ)-4-((ｒ)-2-(벤질옥시)트라이데실)-3-헥실-2-옥세타논의 제조방법 및 이에 사용되는 중간체
CN102086184A (zh) * 2011-03-03 2011-06-08 上海应用技术学院 5位氟取代的4-羟基-3,4,5,6-四氢-2h-吡喃-2-酮类化合物及其制备方法
CA2944989A1 (en) 2013-04-08 2014-10-16 Cytodyn Inc. Felinized antibodies and methods of treating retroviral infections in felines
ES2524647B1 (es) * 2013-06-06 2015-09-15 Neuron Bio, S.A. Compuestos neuroprotectores, antiinflamatorios y antiepilépticos

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4137322A (en) 1976-11-02 1979-01-30 Sankyo Company Limited ML-236B carboxylic acid derivatives and their use as antihyperlipemic agents
ES493726A0 (es) 1979-07-27 1981-06-16 Sankyo Co Un procedimiento para la preparacion de sales y esteres, de monacolina k utiles como agentes antitlipercolesteremicos.
JPS56142236A (en) 1980-04-08 1981-11-06 Sankyo Co Ltd Ml-236a and mb-530a derivative
US4343814A (en) 1980-11-17 1982-08-10 Merck & Co., Inc. Hypocholesterolemic fermentation products
EP0068038B1 (en) 1981-06-29 1985-09-25 Merck & Co. Inc. (+)-(4r,6s)-(e)-6-(2-(4'-fluoro-3,3',5-trimethyl-(1,1'-biphenyl)-2-yl)ethenyl)-3,4,5,6-tetrahydro-4-hydroxy-2h-pyran-2-one, a process for preparing and a pharmaceutical composition containing the same
US4582915A (en) * 1983-10-11 1986-04-15 Merck & Co., Inc. Process for C-methylation of 2-methylbutyrates
US6376683B1 (en) * 2001-06-01 2002-04-23 Council Of Scientific & Industrial Research Process for the preparation of (4R,6S)-4-hydroxy-6-hydroxymethyl-tetrahydropyran-2-one

Also Published As

Publication number Publication date
JP2005500282A (ja) 2005-01-06
CA2450617A1 (en) 2002-12-19
WO2002100323A3 (en) 2003-09-18
BR0210426A (pt) 2004-08-17
US6541511B1 (en) 2003-04-01
ZA200400017B (en) 2004-10-25
EP1404313A2 (en) 2004-04-07
EP1404313A4 (en) 2006-01-18
CN1535145A (zh) 2004-10-06
EA200400034A1 (ru) 2004-06-24
CZ200450A3 (cs) 2004-05-12
WO2002100323A2 (en) 2002-12-19
PL367885A1 (en) 2005-03-07

Similar Documents

Publication Publication Date Title
JP2843627B2 (ja) コレステロール合成の阻害剤トランス‐６‐〔２‐（置換ピロール‐１‐イル）アルキル〕ピラン‐２‐オンの改良法
FI94339B (fi) Menetelmä farmaseuttisesti käyttökelpoisen /R-(R*,R*)/-2-(4-fluorifenyyli)- , -dihydroksi-5-(1-metyylietyyli)-3-fenyyli-4-/(fenyyliamino)karbonyyli/-1H-pyrroli-1-heptaanihapon ja sen farmaseuttisesti hyväksyttävien suolojen valmistamiseksi
SK12012002A3 (sk) Spôsob purifikácie fermentačného bujónu
DE69612086T2 (de) Verfahren zur herstellung von (+)compactin und (+)mevinolin derivaten mit beta-hydroxy-delta-lactonresten
EP0323867B1 (en) Novel hmg-coa reductase inhibitors
FI91960B (fi) Menetelmä lääkeaineena käyttökelpoisten oktahydronaftaleenioksiimin johdannaisten valmistamiseksi
US6686481B2 (en) Highly purified simvastatin compositions
AU2001282981A1 (en) Highly purified simvastatin compositions
SK242004A3 (en) Methyl analogs of simvastatin as novel HMG-CoA reductase inhibitors
JPH02745A (ja) 新規なＨＭＧ―ＣｏＡ還元酵素阻害剤
JP2003525935A (ja) 低下したレベルの二量体不純物を伴うロバスタチン及びシンバスタチンの精製方法
IE63491B1 (en) New 6-fluoro-3,5-dihydroxy carboxylic acids and derivatives thereof, a process for the preparation thereof, the use thereof as medicinal agents, pharmaceutical products and intermediates
US5177104A (en) 6-α-hydroxy derivatives of mevinic acids
US5089523A (en) Fluorinated derivatives of mevinic acids
EP0420266A2 (en) Chromene or thiochromene derivatives, process for preparing the same, intermediate therefor, pharmaceutical compositions containing said derivatives and the use of said derivatives
AU2002304343A1 (en) Methyl analogs of simvastatin as novel HMG-CoA reductase inhibitors
US5286746A (en) Sulfur-substituted mevinic acid derivatives
JPH03173848A (ja) メビン酸誘導体
KR20030045340A (ko) 스타틴의 제조에 있어서 새로운 락톤화 방법
NL8007028A (nl) 1,2,3,4,4a,9b-hexahydro-4-hydroxy dibenzofuranen.
EP1693360A1 (en) Huvastatin and its preparation and formulation comprising the huvastatin
MXPA01010721A (es) Metodo para la obtencion de simvastatina a partir de lovastatina.
NZ200588A (en) 6(r)-(2-(8(s)-(2,2-dimethylbutyryloxy)-2(s),6(s)-dimethyl-1,2,3,4,4a(s),5,6,7,8,8a(s)-decahydronaphthyl-1(s))-ethyl)-4(r)-hydroxy-3,4,5,6-tetrahydro-2h-pyran-2-one and pharmaceutical compositions
IE53256B1 (en) 6(r)-(2-(8(s)(2,2-dimethylbutyryloxy)-2(s),6(s)-dimethyl-1,2,3,4,4a(s),5,6,7,8,8a(s)-decahydronaphthyl-1(s))ethyl)-4(r)-hydroxy-3,4,5,6-tetrahydro-2h-pyran-2-one